ContraVir Pharmaceuticals (CTRV) Stock Price Down 6.8%

ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) shares were down 6.8% on Thursday . The stock traded as low as $0.38 and last traded at $0.41. Approximately 1,631,100 shares changed hands during mid-day trading, an increase of 75% from the average daily volume of 934,181 shares. The stock had previously closed at $0.44.

Separately, Maxim Group reaffirmed a “buy” rating and issued a $4.00 price target on shares of ContraVir Pharmaceuticals in a report on Thursday, August 24th.

An institutional investor recently raised its position in ContraVir Pharmaceuticals stock. Vanguard Group Inc. increased its stake in ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) by 17.9% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,414,475 shares of the biopharmaceutical company’s stock after acquiring an additional 366,192 shares during the period. Vanguard Group Inc. owned about 3.79% of ContraVir Pharmaceuticals worth $1,400,000 as of its most recent SEC filing. 6.65% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: “ContraVir Pharmaceuticals (CTRV) Stock Price Down 6.8%” was first published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://sportsperspectives.com/2017/12/09/contravir-pharmaceuticals-ctrv-stock-price-down-6-8.html.

ContraVir Pharmaceuticals Company Profile

Receive News & Ratings for ContraVir Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraVir Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply